Phytopharm PLC Shares Soar on Parkinson’s Drug Promise; Stock Up 339.64% at Market Close

Reuters -- British biotech minnow Phytopharm reported promising early test results with its Parkinson's disease drug Cogane on Wednesday, propelling the stock as much as 350 percent higher.